The global pet herbal supplements market size is evaluated at USD 1.18 billion in 2025 and is forecasted to hit around USD 2.96 billion by 2034, growing at a CAGR of 10.71% from 2025 to 2034. The North America market size accounted for USD 353.10 million in 2024 and is expanding at a CAGR of 10.87% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Pet Herbal Supplements Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Pet Herbal Supplements Market Revenue and Volume, by Product Type
8.1.1. Omega-3 Fatty Acids
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Probiotics & Prebiotics
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Multivitamins & Minerals
8.1.3.1. Market Revenue and Volume Forecast
8.1.4. CBD
8.1.4.1. Market Revenue and Volume Forecast
8.1.5. Proteins & Peptides
8.1.5.1. Market Revenue and Volume Forecast
8.1.6. Others
8.1.6.1. Market Revenue and Volume Forecast
9.1. Pet Herbal Supplements Market Revenue and Volume, by Application
9.1.1. Digestive Support
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Immunity Support
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Skin & Coat
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Calming/Stress/Anxiety
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Joint Health Support
9.1.5.1. Market Revenue and Volume Forecast
9.1.6. Kidney Health
9.1.6.1. Market Revenue and Volume Forecast
9.1.7. Liver Health
9.1.7.1. Market Revenue and Volume Forecast
9.1.8. Respiratory Health
9.1.8.1. Market Revenue and Volume Forecast
9.1.9. Others (energy and electrolytes, growth promoters, etc.)
9.1.9.1. Market Revenue and Volume Forecast
10.1. Pet Herbal Supplements Market Revenue and Volume, by Animal Type
10.1.1. Dogs
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Cats
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Horses
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Others
10.1.4.1. Market Revenue and Volume Forecast
11.1. Pet Herbal Supplements Market Revenue and Volume, by Dosage Form
11.1.1. Tablets & Capsules
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Gummies & Chewable
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Powders
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Liquids
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Volume Forecast
12.1. Pet Herbal Supplements Market Revenue and Volume, by Distribution Channel
12.1.1. Online
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Offline
12.1.2.1. Market Revenue and Volume Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product Type
13.1.2. Market Revenue and Volume Forecast, by Application
13.1.3. Market Revenue and Volume Forecast, by Animal Type
13.1.4. Market Revenue and Volume Forecast, by Dosage Form
13.1.5. Market Revenue and Volume Forecast, by Distribution Channel
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product Type
13.1.6.2. Market Revenue and Volume Forecast, by Application
13.1.6.3. Market Revenue and Volume Forecast, by Animal Type
13.1.6.4. Market Revenue and Volume Forecast, by Dosage Form
13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product Type
13.1.7.2. Market Revenue and Volume Forecast, by Application
13.1.7.3. Market Revenue and Volume Forecast, by Animal Type
13.1.7.4. Market Revenue and Volume Forecast, by Dosage Form
13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product Type
13.2.2. Market Revenue and Volume Forecast, by Application
13.2.3. Market Revenue and Volume Forecast, by Animal Type
13.2.4. Market Revenue and Volume Forecast, by Dosage Form
13.2.5. Market Revenue and Volume Forecast, by Distribution Channel
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product Type
13.2.6.2. Market Revenue and Volume Forecast, by Application
13.2.6.3. Market Revenue and Volume Forecast, by Animal Type
13.2.7. Market Revenue and Volume Forecast, by Dosage Form
13.2.8. Market Revenue and Volume Forecast, by Distribution Channel
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product Type
13.2.9.2. Market Revenue and Volume Forecast, by Application
13.2.9.3. Market Revenue and Volume Forecast, by Animal Type
13.2.10. Market Revenue and Volume Forecast, by Dosage Form
13.2.11. Market Revenue and Volume Forecast, by Distribution Channel
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product Type
13.2.12.2. Market Revenue and Volume Forecast, by Application
13.2.12.3. Market Revenue and Volume Forecast, by Animal Type
13.2.12.4. Market Revenue and Volume Forecast, by Dosage Form
13.2.13. Market Revenue and Volume Forecast, by Distribution Channel
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product Type
13.2.14.2. Market Revenue and Volume Forecast, by Application
13.2.14.3. Market Revenue and Volume Forecast, by Animal Type
13.2.14.4. Market Revenue and Volume Forecast, by Dosage Form
13.2.15. Market Revenue and Volume Forecast, by Distribution Channel
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product Type
13.3.2. Market Revenue and Volume Forecast, by Application
13.3.3. Market Revenue and Volume Forecast, by Animal Type
13.3.4. Market Revenue and Volume Forecast, by Dosage Form
13.3.5. Market Revenue and Volume Forecast, by Distribution Channel
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product Type
13.3.6.2. Market Revenue and Volume Forecast, by Application
13.3.6.3. Market Revenue and Volume Forecast, by Animal Type
13.3.6.4. Market Revenue and Volume Forecast, by Dosage Form
13.3.7. Market Revenue and Volume Forecast, by Distribution Channel
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product Type
13.3.8.2. Market Revenue and Volume Forecast, by Application
13.3.8.3. Market Revenue and Volume Forecast, by Animal Type
13.3.8.4. Market Revenue and Volume Forecast, by Dosage Form
13.3.9. Market Revenue and Volume Forecast, by Distribution Channel
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product Type
13.3.10.2. Market Revenue and Volume Forecast, by Application
13.3.10.3. Market Revenue and Volume Forecast, by Animal Type
13.3.10.4. Market Revenue and Volume Forecast, by Dosage Form
13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product Type
13.3.11.2. Market Revenue and Volume Forecast, by Application
13.3.11.3. Market Revenue and Volume Forecast, by Animal Type
13.3.11.4. Market Revenue and Volume Forecast, by Dosage Form
13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product Type
13.4.2. Market Revenue and Volume Forecast, by Application
13.4.3. Market Revenue and Volume Forecast, by Animal Type
13.4.4. Market Revenue and Volume Forecast, by Dosage Form
13.4.5. Market Revenue and Volume Forecast, by Distribution Channel
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product Type
13.4.6.2. Market Revenue and Volume Forecast, by Application
13.4.6.3. Market Revenue and Volume Forecast, by Animal Type
13.4.6.4. Market Revenue and Volume Forecast, by Dosage Form
13.4.7. Market Revenue and Volume Forecast, by Distribution Channel
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product Type
13.4.8.2. Market Revenue and Volume Forecast, by Application
13.4.8.3. Market Revenue and Volume Forecast, by Animal Type
13.4.8.4. Market Revenue and Volume Forecast, by Dosage Form
13.4.9. Market Revenue and Volume Forecast, by Distribution Channel
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product Type
13.4.10.2. Market Revenue and Volume Forecast, by Application
13.4.10.3. Market Revenue and Volume Forecast, by Animal Type
13.4.10.4. Market Revenue and Volume Forecast, by Dosage Form
13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product Type
13.4.11.2. Market Revenue and Volume Forecast, by Application
13.4.11.3. Market Revenue and Volume Forecast, by Animal Type
13.4.11.4. Market Revenue and Volume Forecast, by Dosage Form
13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product Type
13.5.2. Market Revenue and Volume Forecast, by Application
13.5.3. Market Revenue and Volume Forecast, by Animal Type
13.5.4. Market Revenue and Volume Forecast, by Dosage Form
13.5.5. Market Revenue and Volume Forecast, by Distribution Channel
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product Type
13.5.6.2. Market Revenue and Volume Forecast, by Application
13.5.6.3. Market Revenue and Volume Forecast, by Animal Type
13.5.6.4. Market Revenue and Volume Forecast, by Dosage Form
13.5.7. Market Revenue and Volume Forecast, by Distribution Channel
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product Type
13.5.8.2. Market Revenue and Volume Forecast, by Application
13.5.8.3. Market Revenue and Volume Forecast, by Animal Type
13.5.8.4. Market Revenue and Volume Forecast, by Dosage Form
13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel
14.1. Blackmores
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. NaturVet (The Garmon Corp.)
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Natural Dog Company Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. AdvaCare Pharma
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Pet Natural Remedies
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Dorwest Herbs Ltd.
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Only Natural Pet LLC
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. AMORVET
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Rockwell Pets Pro
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Nutri-Pet Research, Inc.
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client